The ASNS inhibitor ASX-173 potentiates L-asparaginase anticancer activity
Victor Vyacheslavovich Tatarskiy, Wai-Kin Chan, Lin Tan…·Philip L. Lorenzi
The paper identifies ASX-173 as a potent ASNS inhibitor that enhances the anti-cancer effects of L-asparaginase in leukemia and shows its potential across multiple cancer types.